A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer

European Urology

Volumn 33, Issue 3, 1998, Pages 285-289

  Okamura, K ^a   Kinukawa, T ^a   Tsumura, Y ^a   Otani, T ^a   Itoh, H ^a   Kobayashi, H ^a   Matsuura, O ^a   Kobayashi, M ^a   Fukatsu, T ^a   Ohshima, S ^a   Oosterlinck, W ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapeutic agent; Epirubicin; Prophylactic treatment; Superficial bladder cancer

Indexed keywords

ANTIINFECTIVE AGENT; EPIRUBICIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER IRRITATION; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATURIA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 6844252900     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019581     Document Type: Article

References (13)